Literature DB >> 6811577

Evidence that warfarin anticoagulant action involves two distinct reductase activities.

M J Fasco, E F Hildebrandt, J W Suttie.   

Abstract

The dithiothreitol-dependent vitamin K and vitamin K 2,3-epoxide hepatic microsomal reductase activities of warfarin-susceptible and warfarin-resistant rats were compared to gain insight into the role(s) of these activities in vitamin K metabolism and function. In microsomes from resistant rats, 3- to 4-fold more warfarin was required to produce 50% inhibition (I50) of vitamin K reduction to vitamin K hydroquinone than in microsomes from susceptible rats. For the reduction of vitamin K 2,3-epoxide to vitamin K a 6-fold higher warfarin concentration was required. In microsomes from resistant rats, the I50 warfarin concentration required to inhibit gamma-carboxylation of microsomal precursor protein was also 4-fold higher with vitamin K as substrate and was 6-fold higher with the epoxide as substrate than in microsomes from susceptible rats. Collectively, these data suggest that the vitamin K reductase contributes to the metabolism of vitamin K in intact rats and that warfarin inhibition of both the vitamin K and vitamin K 2,3-epoxide reductases is involved in its anticoagulant effect.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6811577

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  [Role of vitamin K antagonists from a hepatologist's point of view].

Authors:  G Kneiseler; A Canbay; G Gerken
Journal:  Herz       Date:  2012-06       Impact factor: 1.443

3.  Vitamin K antagonism of coumarin anticoagulation. A dehydrogenase pathway in rat liver is responsible for the antagonistic effect.

Authors:  R Wallin
Journal:  Biochem J       Date:  1986-06-15       Impact factor: 3.857

Review 4.  Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase.

Authors:  C Vermeer
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

5.  Warfarin and vitamin K compete for binding to Phe55 in human VKOR.

Authors:  Katrin J Czogalla; Arijit Biswas; Klara Höning; Veit Hornung; Kerstin Liphardt; Matthias Watzka; Johannes Oldenburg
Journal:  Nat Struct Mol Biol       Date:  2016-12-12       Impact factor: 15.369

Review 6.  Anticoagulation therapy in children.

Authors:  Milind D Ronghe; Christina Halsey; Nicholas J Goulden
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

7.  A cardiovascular phenotype in warfarin-resistant Vkorc1 mutant rats.

Authors:  Michael H Kohn; Roger E Price; Hans-Joachim Pelz
Journal:  Artery Res       Date:  2008-11       Impact factor: 0.597

8.  Growth inhibitory actions of prothrombin on normal hepatocytes: influence of matrix.

Authors:  Brian I Carr; Siddhartha Kar; Meifang Wang; Ziqiu Wang
Journal:  Cell Biol Int       Date:  2007-03-19       Impact factor: 3.612

9.  Warfarin poisoning and vitamin K antagonism in rat and human liver. Design of a system in vitro that mimics the situation in vivo.

Authors:  R Wallin; L F Martin
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

10.  Molecular geometry, vibrations and electrode potentials of 2-(4,5-dihydroxy-2-methylphenyl)-2-phenyl-2H-indene-1,3-dione; experimental and theoretical attempts.

Authors:  Siavash Riahi; Mohammad Reza Ganjali; Abdolmajid Bayandori Moghaddam; Parviz Norouzi
Journal:  J Mol Model       Date:  2008-02-15       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.